Paolo Giuseppe Limoli, Celeste Limoli, Marcella Nebbioso
Cataracts can reduce the quality of vision in visually impaired patients who already have a visual impairment. The most common causes of low vision include age-related macular degeneration (AMD), high myopia (HM), diabetic retinopathy (DR), glaucoma (GL), and inherited degenerative ocular diseases. The surgery aims to improve their independence, quality of life, and ability to engage in daily, social, and work activities. Phacoemulsification and intraocular lens (IOL) implantation, combined with visual rehabilitation, can improve visual acuity of visually impaired patients. Therefore, comprehensive guidelines for cataract surgery in patients with low vision would be beneficial to ensure optimal surgical outcomes by improving surgical planning, execution, and postoperative care, along with a well-coordinated rehabilitation process. In cases of reduced metabolism, such as low vision, oxidative stress can be aggravated by light exposure and surgical interventions. Thus, maintaining redox balance is crucial for stabilizing retinal conditions. Patients with visual impairments rely on retinal regions with the greatest residual function, and cataract surgery aims to enhance focus on these areas, improving reading quality and reducing scotoma perception. Thorough informed consent is crucial, ensuring that patients are fully aware of the potential risks, benefits, and limitations of surgery. Close postoperative follow-up in the first 6 months is crucial to detect and manage any complications promptly, such as reactivation of maculopathy. The aim of this work is to establish potential guidelines for optimal rehabilitation outcomes through careful literature analysis.
{"title":"Potential guidelines for cataract surgery and rehabilitation in visually impaired patients: Literature analysis","authors":"Paolo Giuseppe Limoli, Celeste Limoli, Marcella Nebbioso","doi":"10.1002/agm2.12386","DOIUrl":"10.1002/agm2.12386","url":null,"abstract":"<p>Cataracts can reduce the quality of vision in visually impaired patients who already have a visual impairment. The most common causes of low vision include age-related macular degeneration (AMD), high myopia (HM), diabetic retinopathy (DR), glaucoma (GL), and inherited degenerative ocular diseases. The surgery aims to improve their independence, quality of life, and ability to engage in daily, social, and work activities. Phacoemulsification and intraocular lens (IOL) implantation, combined with visual rehabilitation, can improve visual acuity of visually impaired patients. Therefore, comprehensive guidelines for cataract surgery in patients with low vision would be beneficial to ensure optimal surgical outcomes by improving surgical planning, execution, and postoperative care, along with a well-coordinated rehabilitation process. In cases of reduced metabolism, such as low vision, oxidative stress can be aggravated by light exposure and surgical interventions. Thus, maintaining redox balance is crucial for stabilizing retinal conditions. Patients with visual impairments rely on retinal regions with the greatest residual function, and cataract surgery aims to enhance focus on these areas, improving reading quality and reducing scotoma perception. Thorough informed consent is crucial, ensuring that patients are fully aware of the potential risks, benefits, and limitations of surgery. Close postoperative follow-up in the first 6 months is crucial to detect and manage any complications promptly, such as reactivation of maculopathy. The aim of this work is to establish potential guidelines for optimal rehabilitation outcomes through careful literature analysis.</p>","PeriodicalId":32862,"journal":{"name":"Aging Medicine","volume":"7 6","pages":"802-812"},"PeriodicalIF":2.2,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11702492/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142955940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p>According to the latest official report, the incidence and mortality rates of cardiovascular diseases continue to rise in China.<span><sup>1</sup></span> Among these, coronary heart disease (CHD) represents the most significant threat to public health and imposes substantial social burdens. Percutaneous coronary intervention (PCI) has rapidly advanced as a key treatment modality for CHD. With an aging population, the number of PCIs performed in China is projected to increase over the long term. To enhance the prognosis for patients with CHD, it is essential to improve the quality of care while ensuring a reasonable growth in the volume of procedures. In recent years, intravascular imaging-guided PCI has emerged as a crucial approach for the precise optimization of PCI procedures in clinical practice. This imaging primarily encompasses intravascular ultrasound (IVUS) and optical coherence tomography (OCT). Since the 1990s, a wealth of clinical evidence has been published regarding the efficacy and safety of IVUS.<span><sup>2, 3</sup></span> However, despite OCT's superior image resolution, high-quality evidence concerning its impact on patient prognosis remains limited due to its more recent application. Results from two clinical trials comparing OCT-guided PCI with angiography-guided PCI were presented at the European Society of Cardiology Annual Meeting 2023 and subsequently published in the New England Journal of Medicine. The OCTOBER study demonstrated that OCT-guided PCI enhances clinical outcomes for complex bifurcation lesions.<span><sup>4</sup></span> Conversely, the ILUMIEN IV study reported negative findings. Although OCT-guided PCI achieved a larger postoperative minimum stent area (MSA) in clinically high-risk patients and/or high-risk coronary lesions, there was no significant difference in the incidence of target vessel failure (TVF) at 2 years between the two groups.<span><sup>5</sup></span> These contrasting results invite a deeper examination of the prognostic value of OCT-guided PCI. Therefore, this article provides a comprehensive review of the clinical significance and application of OCT-guided PCI in elderly patients, informed by an analysis of these two trials.</p><p>To effectively interpret randomized controlled trials (RCTs) and integrate their findings into clinical practice, adherence to the “PICOS principle,” which encompasses Population, Intervention, Comparison, Outcome, and Study design, is crucial. An analysis of the two clinical trials presented in Table 1 highlights that both studies are direct RCTs assessing the effectiveness of OCT compared to angiography-guided PCI and share similar definitions for their primary end points. However, the inclusion criteria exhibit notable differences. The OCTOBER study is dedicated to validating the use of OCT specifically in true bifurcation lesions with clear indications for PCI. In contrast, the ILUMIEN IV study considers a more diverse population with a wider range of lesi
{"title":"OCT-guided PCI in elderly patients","authors":"Yanwen Fang, Mengyue Yu","doi":"10.1002/agm2.12381","DOIUrl":"10.1002/agm2.12381","url":null,"abstract":"<p>According to the latest official report, the incidence and mortality rates of cardiovascular diseases continue to rise in China.<span><sup>1</sup></span> Among these, coronary heart disease (CHD) represents the most significant threat to public health and imposes substantial social burdens. Percutaneous coronary intervention (PCI) has rapidly advanced as a key treatment modality for CHD. With an aging population, the number of PCIs performed in China is projected to increase over the long term. To enhance the prognosis for patients with CHD, it is essential to improve the quality of care while ensuring a reasonable growth in the volume of procedures. In recent years, intravascular imaging-guided PCI has emerged as a crucial approach for the precise optimization of PCI procedures in clinical practice. This imaging primarily encompasses intravascular ultrasound (IVUS) and optical coherence tomography (OCT). Since the 1990s, a wealth of clinical evidence has been published regarding the efficacy and safety of IVUS.<span><sup>2, 3</sup></span> However, despite OCT's superior image resolution, high-quality evidence concerning its impact on patient prognosis remains limited due to its more recent application. Results from two clinical trials comparing OCT-guided PCI with angiography-guided PCI were presented at the European Society of Cardiology Annual Meeting 2023 and subsequently published in the New England Journal of Medicine. The OCTOBER study demonstrated that OCT-guided PCI enhances clinical outcomes for complex bifurcation lesions.<span><sup>4</sup></span> Conversely, the ILUMIEN IV study reported negative findings. Although OCT-guided PCI achieved a larger postoperative minimum stent area (MSA) in clinically high-risk patients and/or high-risk coronary lesions, there was no significant difference in the incidence of target vessel failure (TVF) at 2 years between the two groups.<span><sup>5</sup></span> These contrasting results invite a deeper examination of the prognostic value of OCT-guided PCI. Therefore, this article provides a comprehensive review of the clinical significance and application of OCT-guided PCI in elderly patients, informed by an analysis of these two trials.</p><p>To effectively interpret randomized controlled trials (RCTs) and integrate their findings into clinical practice, adherence to the “PICOS principle,” which encompasses Population, Intervention, Comparison, Outcome, and Study design, is crucial. An analysis of the two clinical trials presented in Table 1 highlights that both studies are direct RCTs assessing the effectiveness of OCT compared to angiography-guided PCI and share similar definitions for their primary end points. However, the inclusion criteria exhibit notable differences. The OCTOBER study is dedicated to validating the use of OCT specifically in true bifurcation lesions with clear indications for PCI. In contrast, the ILUMIEN IV study considers a more diverse population with a wider range of lesi","PeriodicalId":32862,"journal":{"name":"Aging Medicine","volume":"7 6","pages":"676-678"},"PeriodicalIF":2.2,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11702369/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142955934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}